
Novavax’s COVID-19 vaccine shown to be nearly 90% effective in UK clinical trial; immunity against new variants mixed. The findings showed the vaccine also provided strong immunity against the UK variant, but another interim study found limited effectiveness against the variant from South Africa. Ref. USAToday.